Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Cohn

Showing results (131-140 of 302) with videos related to

Pageof 31
Sort By:
NPJ Precision Oncology|February 8, 2025
Molecular characterization of mixed-histology endometrial carcinoma provides prognostic and therapeutic value over morphologic findingsPaulina J Haight, Ashwini Esnakula, Courtney J Riedinger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 28, 2019
Intentional weight loss, weight cycling, and endometrial cancer risk: a systematic review and meta-analysisXiaochen Zhang, Jennifer Rhoades, Bette J Caan, et al.
Gynecologic Oncology|February 16, 2010
Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancerKimberly E Resnick, Wendy L Frankel, Carl D Morrison, et al.
American Journal of Obstetrics and Gynecology|March 14, 2022
More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancerDavid A Barrington, Jennifer A Sinnott, Danaye Nixon, et al.
Gynecologic Oncology|October 3, 2008
Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancerDebra L Richardson, Floor J Backes, Leigh G Seamon, et al.
Gynecologic Oncology|August 12, 2011
A black raspberry extract inhibits proliferation and regulates apoptosis in cervical cancer cellsZhaoxia Zhang, Thomas J Knobloch, Leigh G Seamon, et al.
Gynecologic Oncology|May 15, 2018
Detection of endometrial cancer cells in the fallopian tube lumen is associated with adverse prognostic factors and reduced survivalAshley S Felix, Jennifer A Sinnott, Monica Hagan Vetter, et al.
Gynecologic Oncology|March 16, 2024
An SGO commentary: U.S. News and World Report gynecologic oncology procedural ratings-Do they reflect high-quality care?Amanda N Fader, Emily M Ko, Benjamin D Pollock, et al.
Gynecologic Oncology|May 7, 2022
Less is more: Abdominal closure protocol does not reduce surgical site infection after hysterectomyJoseph A DeMari, Glenn P Boyles, David A Barrington, et al.
Gynecologic Oncology|December 3, 2014
A cost-utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancerDavid E Cohn, Jason C Barnett, Lari Wenzel, et al.
Pageof 31

Showing results (131-140 of 302) with videos related to

Sort By:
Pageof 31
NPJ Precision Oncology|February 8, 2025
Molecular characterization of mixed-histology endometrial carcinoma provides prognostic and therapeutic value over morphologic findingsPaulina J Haight, Ashwini Esnakula, Courtney J Riedinger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 28, 2019
Intentional weight loss, weight cycling, and endometrial cancer risk: a systematic review and meta-analysisXiaochen Zhang, Jennifer Rhoades, Bette J Caan, et al.
Gynecologic Oncology|February 16, 2010
Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancerKimberly E Resnick, Wendy L Frankel, Carl D Morrison, et al.
American Journal of Obstetrics and Gynecology|March 14, 2022
More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancerDavid A Barrington, Jennifer A Sinnott, Danaye Nixon, et al.
Gynecologic Oncology|October 3, 2008
Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancerDebra L Richardson, Floor J Backes, Leigh G Seamon, et al.
Gynecologic Oncology|August 12, 2011
A black raspberry extract inhibits proliferation and regulates apoptosis in cervical cancer cellsZhaoxia Zhang, Thomas J Knobloch, Leigh G Seamon, et al.
Gynecologic Oncology|May 15, 2018
Detection of endometrial cancer cells in the fallopian tube lumen is associated with adverse prognostic factors and reduced survivalAshley S Felix, Jennifer A Sinnott, Monica Hagan Vetter, et al.
Gynecologic Oncology|March 16, 2024
An SGO commentary: U.S. News and World Report gynecologic oncology procedural ratings-Do they reflect high-quality care?Amanda N Fader, Emily M Ko, Benjamin D Pollock, et al.
Gynecologic Oncology|May 7, 2022
Less is more: Abdominal closure protocol does not reduce surgical site infection after hysterectomyJoseph A DeMari, Glenn P Boyles, David A Barrington, et al.
Gynecologic Oncology|December 3, 2014
A cost-utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancerDavid E Cohn, Jason C Barnett, Lari Wenzel, et al.
Pageof 31